TVRD
Tvardi Therapeutics, Inc.
-0.02 (-1.16%)1.71USD55.8K成交股數22.8M市值42.8本益比(近四季)3.0股價營收比–營收年增(近四季)2026-11-12下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0 · 0 |
| 近 180 天 淨額 | 0 |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2025-07-07 | 08-05 | Tweardy Samuel David | TenPercentOwner | J 其他 | 316K | – | – | 0 | SEC |
| 2025-07-07 | 08-05 | Tweardy Samuel David | TenPercentOwner | J 其他 | 316K | – | – | 0 | SEC |
| 2025-04-15 | 05-02 | Wirk Shaheen | Director | A 獲配股票 | 263K | – | – | 263K | SEC |
| 2025-04-15 | 05-02 | Wirk Shaheen | Director | A 獲配股票 | 176K | – | – | 176K | SEC |
| 2025-04-15 | 05-02 | HALL WALLACE L JR | Director | A 獲配股票 | 44.7K | – | – | 44.7K | SEC |
| 2025-04-15 | 05-02 | HALL WALLACE L JR | Director | A 獲配股票 | 202K | – | – | 202K | SEC |
| 2025-04-15 | 04-17 | Wirk Shaheen | Director | J 其他 | 263K | – | – | 263K | SEC |
| 2025-04-15 | 04-17 | Wirk Shaheen | Director | A 獲配股票 | 4.2K | – | – | 4.2K | SEC |
| 2025-04-15 | 04-17 | HALL WALLACE L JR | Director | J 其他 | 202K | – | – | 202K | SEC |
| 2025-04-15 | 04-17 | HALL WALLACE L JR | Director | J 其他 | 44.7K | – | – | 44.7K | SEC |
| 2025-04-15 | 04-17 | Wirk Shaheen | Director | J 其他 | 176K | – | – | 176K | SEC |
| 2025-02-28 | 03-04 | Terrillion Scott | SEC'Y; CHIEF COMPLIANCE & G.C. | S 公開市場賣出 | 163 | 4.76 | 775.88 | 7.2K | SEC |
| 2025-02-28 | 03-04 | Posner Christopher | PRESIDENT AND CEO | S 公開市場賣出 | 583 | 4.75 | 3K | 13.1K | SEC |
| 2025-02-04 | 02-06 | Posner Christopher | PRESIDENT AND CEO | S 公開市場賣出 | 372 | 4.72 | 2K | 13.7K | SEC |
| 2024-11-04 | 11-06 | Posner Christopher | PRESIDENT AND CEO | S 公開市場賣出 | 3.7K | 0.29 | 1K | 169K | SEC |
| 2024-08-01 | 08-02 | Posner Christopher | PRESIDENT AND CEO | S 公開市場賣出 | 4.1K | 0.35 | 1K | 172K | SEC |
| 2024-06-04 | 06-06 | Boudreau Helen M | Director | A 獲配股票 | 151K | – | – | 151K | SEC |
| 2024-06-04 | 06-06 | von Moltke Lisa | Director | A 獲配股票 | 151K | – | – | 183K | SEC |
| 2024-06-04 | 06-06 | Shiff Susan Ph.D. | Director | A 獲配股票 | 151K | – | – | 202K | SEC |
| 2024-06-04 | 06-06 | VOGELBAUM MARTIN | Director | A 獲配股票 | 301K | – | – | 411K | SEC |
| 2024-06-04 | 06-06 | Ives Jeffrey L. | Director | A 獲配股票 | 151K | – | – | 198K | SEC |
| 2024-05-02 | 05-06 | Posner Christopher | PRESIDENT AND CEO | S 公開市場賣出 | 3.9K | 0.75 | 3K | 177K | SEC |
| 2024-04-05 | 04-09 | Goncalves Joana | CHIEF MEDICAL OFFICER | S 公開市場賣出 | 2.8K | 0.83 | 2K | 53.4K | SEC |
| 2024-04-05 | 04-09 | Terrillion Scott | SEC'Y; CHIEF COMPLIANCE & G.C. | S 公開市場賣出 | 2.8K | 0.83 | 2K | 88.2K | SEC |
| 2024-02-29 | 03-04 | Goncalves Joana | CHIEF MEDICAL OFFICER | S 公開市場賣出 | 3.3K | 0.89 | 3K | 56.1K | SEC |
| 2024-02-29 | 03-04 | Posner Christopher | PRESIDENT AND CEO | S 公開市場賣出 | 5.8K | 0.89 | 5K | 181K | SEC |
| 2024-02-29 | 03-04 | Terrillion Scott | SEC'Y; CHIEF COMPLIANCE & G.C. | S 公開市場賣出 | 3.3K | 0.89 | 3K | 91.0K | SEC |
| 2024-02-08 | 02-12 | Posner Christopher | PRESIDENT AND CEO | S 公開市場賣出 | 35.6K | 0.53 | 19K | 186K | SEC |
| 2024-02-01 | 02-05 | Maynard Ryan D | CHIEF FINANCIAL OFFICER | A 獲配股票 | 13.5K | – | – | 13.5K | SEC |
| 2024-02-01 | 02-05 | Posner Christopher | PRESIDENT AND CEO | S 公開市場賣出 | 5.0K | 0.55 | 3K | 222K | SEC |
| 2024-02-01 | 02-05 | Posner Christopher | PRESIDENT AND CEO | A 獲配股票 | 62.5K | – | – | 227K | SEC |
| 2024-02-01 | 02-05 | Terrillion Scott | SEC'Y; CHIEF COMPLIANCE & G.C. | A 獲配股票 | 13.5K | – | – | 102K | SEC |
| 2024-02-01 | 02-05 | Goncalves Joana | CHIEF MEDICAL OFFICER | A 獲配股票 | 13.5K | – | – | 67.2K | SEC |
| 2024-02-01 | 02-05 | Menzaghi Frederique Ph.D. | CHIEF SCIENTIFIC OFF,SVP-R&D | A 獲配股票 | 13.5K | – | – | 167K | SEC |
| 2023-11-02 | 11-03 | Posner Christopher | President and CEO | S 公開市場賣出 | 3.8K | 1.22 | 5K | 164K | SEC |
| 2023-08-03 | 08-04 | Posner Christopher | President and CEO | S 公開市場賣出(10b5-1) | 4.3K | 3.07 | 13K | 168K | SEC |
| 2023-06-23 | 06-27 | Goncalves Joana | Chief Medical Officer | S 公開市場賣出(10b5-1) | 2.7K | 3.51 | 10K | 53.7K | SEC |
| 2023-06-23 | 06-27 | Terrillion Scott | Sec'y; Chief Compliance & G.C. | S 公開市場賣出(10b5-1) | 2.5K | 3.51 | 9K | 88.6K | SEC |
| 2023-06-23 | 06-27 | Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | S 公開市場賣出(10b5-1) | 3.0K | 3.51 | 11K | 154K | SEC |
| 2023-06-01 | 06-05 | von Moltke Lisa | Director | A 獲配股票 | 32.4K | – | – | 32.4K | SEC |
| 2023-06-01 | 06-05 | Shiff Susan Ph.D. | Director | A 獲配股票 | 32.4K | – | – | 51.4K | SEC |
| 2023-06-01 | 06-05 | Ives Jeffrey L. | Director | A 獲配股票 | 32.4K | – | – | 47.8K | SEC |
| 2023-06-01 | 06-05 | BAINS HARRISON M JR | Director | A 獲配股票 | 32.4K | – | – | 57.4K | SEC |
| 2023-06-01 | 06-05 | VOGELBAUM MARTIN | Director | A 獲配股票 | 64.7K | – | – | 110K | SEC |
| 2023-05-05 | 05-09 | Posner Christopher | President and CEO | S 公開市場賣出(10b5-1) | 3.9K | 4.40 | 17K | 173K | SEC |
| 2023-04-04 | 04-06 | Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | S 公開市場賣出 | 2.7K | 4.91 | 13K | 157K | SEC |
| 2023-04-04 | 04-06 | Terrillion Scott | Sec'y; Chief Compliance & G.C. | S 公開市場賣出 | 2.5K | 4.91 | 12K | 91.0K | SEC |
| 2023-04-04 | 04-06 | Goncalves Joana | Chief Medical Officer | S 公開市場賣出 | 2.5K | 4.91 | 12K | 56.4K | SEC |
| 2023-03-03 | 03-07 | Posner Christopher | President and CEO | S 公開市場賣出 | 6.0K | 9.71 | 58K | 176K | SEC |
| 2023-03-03 | 03-07 | Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | S 公開市場賣出 | 6.8K | 9.71 | 66K | 159K | SEC |
| 2023-03-03 | 03-07 | Terrillion Scott | Sec'y; Chief Compliance & G.C. | S 公開市場賣出 | 6.3K | 9.71 | 61K | 93.5K | SEC |
| 2023-03-03 | 03-07 | Goncalves Joana | Chief Medical Officer | S 公開市場賣出 | 6.2K | 9.71 | 60K | 58.9K | SEC |
| 2023-02-16 | 02-17 | Goncalves Joana | Chief Medical Officer | S 公開市場賣出 | 2.3K | 10.20 | 23K | 65.1K | SEC |
| 2023-02-08 | 02-12 | Maynard Ryan D | CHIEF FINANCIAL OFFICER | S 公開市場賣出(10b5-1) | 5.5K | 0.53 | 3K | 8.0K | SEC |
| 2023-02-08 | 02-12 | Goncalves Joana | CHIEF MEDICAL OFFICER | S 公開市場賣出 | 7.8K | 0.53 | 4K | 59.4K | SEC |
| 2023-02-08 | 02-12 | Terrillion Scott | SEC'Y; CHIEF COMPLIANCE & G.C. | S 公開市場賣出 | 7.8K | 0.53 | 4K | 94.3K | SEC |
| 2023-02-02 | 02-03 | Posner Christopher | President and CEO | S 公開市場賣出 | 4.2K | 11.80 | 49K | 182K | SEC |
| 2023-01-17 | 01-19 | Goncalves Joana | Chief Medical Officer | S 公開市場賣出 | 2.3K | 10.81 | 24K | 67.4K | SEC |
| 2022-12-29 | 01-03 | Goncalves Joana | Chief Medical Officer | S 公開市場賣出 | 2.3K | 10.18 | 23K | 69.6K | SEC |
| 2022-12-21 | 12-23 | Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | S 公開市場賣出 | 3.5K | 11.27 | 40K | 166K | SEC |
| 2022-12-21 | 12-23 | Goncalves Joana | Chief Medical Officer | S 公開市場賣出 | 3.0K | 11.27 | 34K | 71.9K | SEC |
| 2022-12-21 | 12-23 | Terrillion Scott | Sec'y; Chief Compliance & G.C. | S 公開市場賣出 | 2.6K | 11.27 | 29K | 99.8K | SEC |
| 2022-11-16 | 11-18 | Posner Christopher | President and CEO | S 公開市場賣出 | 14.5K | 11.13 | 161K | 187K | SEC |
| 2022-09-14 | 09-16 | VOGELBAUM MARTIN | Director | S 公開市場賣出 | 10.8K | 10.28 | 111K | 45.0K | SEC |
| 2022-07-15 | 07-19 | Ives Jeffrey L. | Director | S 公開市場賣出 | 3.6K | 9.05 | 33K | 15.5K | SEC |
| 2022-07-15 | 07-19 | BAINS HARRISON M JR | Director | S 公開市場賣出 | 7.2K | 9.05 | 65K | 25.1K | SEC |
| 2022-06-15 | 06-16 | Makara Richard | VP, Head of Accting;Controller | A 獲配股票 | 7.5K | – | – | 13.6K | SEC |
| 2022-06-02 | 06-06 | VOGELBAUM MARTIN | Director | A 獲配股票 | 23.8K | – | – | 43.9K | SEC |
| 2022-06-02 | 06-06 | Shiff Susan Ph.D. | Director | A 獲配股票 | 11.9K | – | – | 19.1K | SEC |
| 2022-06-02 | 06-06 | BAINS HARRISON M JR | Director | A 獲配股票 | 11.9K | – | – | 32.3K | SEC |
| 2022-06-02 | 06-06 | VOGELBAUM MARTIN | Director | A 獲配股票 | 11.9K | – | – | 55.8K | SEC |
| 2022-06-02 | 06-06 | Ives Jeffrey L. | Director | A 獲配股票 | 11.9K | – | – | 19.1K | SEC |
| 2022-04-04 | 04-05 | Posner Christopher | President and CEO | S 公開市場賣出 | 2.0K | 12.67 | 25K | 201K | SEC |
| 2022-04-01 | 04-05 | Terrillion Scott | Sec'y; Chief Compliance & G.C. | S 公開市場賣出 | 1.6K | 11.91 | 20K | 102K | SEC |
| 2022-04-01 | 04-05 | Goncalves Joana | Chief Medical Officer | S 公開市場賣出 | 1.6K | 11.91 | 20K | 74.9K | SEC |
| 2022-04-01 | 04-05 | Menzaghi Frederique Ph.D. | Chief Scientific Off,SVP-R&D | S 公開市場賣出 | 1.8K | 11.91 | 21K | 170K | SEC |
| 2022-03-03 | 03-04 | Terrillion Scott | Sec'y; Chief Compliance & G.C. | S 公開市場賣出 | 1.8K | 11.38 | 20K | 104K | SEC |
| 2022-03-03 | 03-04 | Reilly Thomas Charles | Chief Financial Officer | S 公開市場賣出 | 2.0K | 11.38 | 23K | 37.8K | SEC |
| 2022-02-28 | 03-01 | Reilly Thomas Charles | Chief Financial Officer | A 獲配股票 | 5.3K | 10.29 | 55K | 39.9K | SEC |
| 2022-02-28 | 03-01 | Terrillion Scott | Sec'y; Chief Compliance & G.C. | A 獲配股票 | 5.3K | – | – | 106K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| Slate Path Capital LP | 704K | 1.3M | 不變 | 持平 |
| VANGUARD CAPITAL MANAGEMENT LLC | 344K | 654K | −326 (-0%) | 減碼 |
| AMERICAN FINANCIAL GROUP INC | 224K | 425K | 不變 | 持平 |
| UBS Group AG | 111K | 211K | +60.7K (+120%) | 加碼 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 101K | 192K | 不變 | 持平 |
| BlackRock, Inc. | 95.5K | 181K | −293K (-75%) | 減碼 |
| 文藝復興 RENAISSANCE TECHNOLOGIES LLC | 91.4K | 174K | −691 (-1%) | 減碼 |
| GEODE CAPITAL MANAGEMENT, LLC | 90.3K | 172K | −92.0K (-50%) | 減碼 |
| MORGAN STANLEY | 77.8K | 148K | +5.0K (+7%) | 加碼 |
| Duncan Williams Asset Management, LLC | 63.2K | 120K | 不變 | 持平 |
| VANGUARD FIDUCIARY TRUST CO | 44.7K | 85K | −2.2K (-5%) | 減碼 |
| Russell Investments Group, Ltd. | 43.2K | 82K | +19.9K (+85%) | 加碼 |
| STATE STREET CORP | 33.9K | 64K | −63.3K (-65%) | 減碼 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 33.2K | 63K | 新進 | 新進 |
| AQR CAPITAL MANAGEMENT LLC | 27.1K | 51K | −15.1K (-36%) | 減碼 |
| Savant Capital, LLC | 19.5K | 49K | 新進 | 新進 |
| NORTHERN TRUST CORP | 21.8K | 41K | −27.2K (-56%) | 減碼 |
| DIADEMA PARTNERS LP | 16.6K | 32K | 新進 | 新進 |
| XTX Topco Ltd | 14.9K | 28K | 新進 | 新進 |
| BROWN ADVISORY INC | 11.2K | 21K | 新進 | 新進 |
| Arax Advisory Partners | 11.0K | 21K | +2.7K (+32%) | 加碼 |
| Qube Research & Technologies Ltd | 10.2K | 19K | 新進 | 新進 |
| Persistent Asset Partners Ltd | 4.3K | 8K | 新進 | 新進 |
| PNC Financial Services Group, Inc. | 3.5K | 7K | +3.0K (+578%) | 加碼 |
| Vanguard Global Advisers, LLC | 3.4K | 6K | 不變 | 持平 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 58 -9 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 13 / 22 / 7 / 22 |
| 機構合計持股 · 佔流通股 | 2.2M · 16.7% |
| 合計季末市值 | 4.2M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 265K |
|---|---|
| 與上期比 | +52.9% |
| 佔流通股數 | 1.99% |
| 日均成交量 | 142K |
| 回補天數 | 1.9 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 265K | +52.9% | 1.99% | 142K | 1.9 |
| 2026-08-14 | 173K | -34.0% | 1.30% | 272K | 1.0 |
| 2026-07-31 | 262K | -51.7% | 1.97% | 793K | 1.0 |
| 2026-07-15 | 543K | +7.0% | 4.07% | 12.5M | 1.0 |
| 2026-06-30 | 507K | +27.5% | 3.80% | 701K | 1.0 |
| 2026-06-15 | 398K | -8.7% | 2.98% | 57.9K | 6.9 |
| 2026-05-29 | 436K | -11.0% | 3.27% | 54.5K | 8.0 |
| 2026-05-15 | 490K | -3.7% | 3.67% | 44.2K | 11.1 |
| 2026-04-30 | 509K | -8.2% | 3.82% | 34.3K | 14.9 |
| 2026-04-15 | 554K | -15.2% | 4.16% | 68.7K | 8.1 |
| 2026-03-31 | 654K | -2.2% | 4.90% | 48.9K | 13.4 |
| 2026-03-13 | 669K | +5.0% | 5.01% | 41.6K | 16.1 |
| 2026-02-27 | 637K | -13.8% | 4.77% | 41.8K | 15.2 |
| 2026-02-13 | 738K | +11.2% | 5.54% | 62.1K | 11.9 |
| 2026-01-30 | 664K | +21.2% | 4.98% | 50.3K | 13.2 |
| 2026-01-15 | 548K | -13.4% | 4.11% | 124K | 4.4 |
| 2025-12-31 | 633K | -29.8% | 4.74% | 162K | 3.9 |
| 2025-12-15 | 902K | -2.5% | 6.76% | 109K | 8.3 |
| 2025-11-28 | 925K | +4.5% | 6.94% | 105K | 8.8 |
| 2025-11-14 | 886K | -13.6% | 6.64% | 189K | 4.7 |
| 2025-10-31 | 1.0M | -12.8% | 7.68% | 421K | 2.4 |
| 2025-10-15 | 1.2M | +38.2% | 8.82% | 851K | 1.4 |
| 2025-09-30 | 851K | +26.0% | 6.38% | 93.8K | 9.1 |
| 2025-09-15 | 675K | -0.8% | 5.06% | 22.2K | 30.4 |
| 2025-08-29 | 680K | +3.0% | 5.10% | 22.5K | 30.2 |
| 2025-08-15 | 661K | +11.2% | 4.95% | 22.4K | 29.4 |